Publicacións (31) Publicacións de XURXO GARCIA OTERO

filter_list

2026

  1. Design and characterization of intravitreal bevacizumab-loaded PLGA nanoparticles: pharmacokinetic and biodistribution impact

    Drug Delivery and Translational Research, Vol. 16, Núm. 4, pp. 1262-1284

  2. Intravitreal faricimab pharmacokinetics assessed by PET imaging in a neovascular Age-related Macular Degeneration rat model

    International Journal of Pharmaceutics: X, Vol. 11

  3. Nanoassemblies for oral protein delivery — The case of monoclonals for inflammatory bowel disease

    Journal of Controlled Release, Vol. 389

2025

  1. A physiologically based pharmacokinetic model to describe [89Zr]Zr-DFO-Adalimumab specific activity after intravitreal administration to rats with endotoxin-induced uveitis

    International Journal of Pharmaceutics, Vol. 681

  2. Intravitreal Administration of Adalimumab-Loaded Poly(Lactic-co-Glycolic Acid) Nanoparticles: Effects on Biodistribution and Pharmacokinetics

    Small Science

  3. Long acting injectables & implants: advances in intraocular drug delivery

    International Journal of Pharmaceutics, Vol. 683

  4. PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model

    International Journal of Pharmaceutics, Vol. 669

2024

  1. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  2. Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study

    International Journal of Molecular Sciences, Vol. 25, Núm. 18

  3. Formulation strategies to improve the bioavailability of poorly absorbed drugs

    Dosage Forms, Formulation Developments and Regulations: Recent and Future Trends in Pharmaceutics, Volume 1, pp. 223-255

  4. Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics

    International Journal of Pharmaceutics, Vol. 662

2023

  1. Antifungal Combination Eye Drops for Fungal Keratitis Treatment

    Pharmaceutics, Vol. 15, Núm. 1

  2. Compression pressure-induced synergy in xanthan and locust bean gum hydrogels. Effect in drug delivery

    Journal of Drug Delivery Science and Technology, Vol. 89

  3. Estudio farmacocinético de adalimumab intravítreo en un modelo de rata con uveítis mediante PET

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2022

  1. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  2. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 172, pp. 144-156

  3. Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery

    Pharmaceutics, Vol. 14, Núm. 4

  4. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

2021

  1. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10

  2. Base preclínica de sistemas lipídicos nanoestructurados (NLC) cargados con bevacizumab: diseño, desarrollo y caracterización fisicoquímica

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 87-89